Cargando…
Proteomics in Pancreatic Cancer Research
Pancreatic cancer is a highly aggressive malignancy with a poor prognosis and deeply affects the life of people. Therefore, the earlier diagnosis and better treatments are urgently needed. In recent years, the proteomic technologies are well established and growing rapidly and have been widely appli...
Autores principales: | Geng, Ruihui, Li, Zhaoshen, Li, Shude, Gao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200191/ https://www.ncbi.nlm.nih.gov/pubmed/22084685 http://dx.doi.org/10.1155/2011/365350 |
Ejemplares similares
-
Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications
por: Sun, Tao, et al.
Publicado: (2014) -
Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
por: Gao, Jun, et al.
Publicado: (2013) -
Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma
por: Wang, Yuqiong, et al.
Publicado: (2016) -
Translational research in anti-pancreatic fibrosis drug discovery and development
por: Ze, Xingyu, et al.
Publicado: (2021) -
Contrast-Enhanced Harmonic Endoscopic Ultrasonography in Pancreatic Diseases
por: Xu, Can, et al.
Publicado: (2012)